CBLL Q3 2024 Earnings — CeriBell, Inc. Revenue & Financial Results | Market Cap Arena

CBLLCeriBell, Inc.

$704M

Q3 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$17M+48.1% YoY

Gross Profit

$15M87.3% margin

Operating Income

-$10M-57.8% margin

Net Income

-$10M-60.6% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+15.7%

Cash Flow

Operating Cash Flow

-$9M

Free Cash Flow

-$9M

Stock-Based Comp.

$1M

Balance Sheet

Total Assets

$47M

Total Liabilities

$183M

Stockholders' Equity

-$136M

Cash & Equivalents

$14M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$12M	+48.1%
Gross Profit	$15M	$10M	+54.3%
Operating Income	-$10M	-$7M	-38.7%
Net Income	-$10M	-$7M	-47.7%